Sexual rehabilitation of men with pituitary tumors
- Autores: Rozhivanov RV1, Kurbatov DG1, Rozhivanov RV1, Kurbatov DG1
-
Afiliações:
- Edição: Nº 4 (2010)
- Páginas: 48-53
- Seção: Articles
- URL: https://journals.eco-vector.com/1728-2985/article/view/277785
- ID: 277785
Citar
Texto integral
Resumo
A prospective trial of the methods of sexual rehabilitation of 31 men with pituitary tumors has shown that therapy with testosterone and chorionic gonadotropin effectively corrects hypogonadism and sexual disorders. In insufficient efficacy normalization of sexual function is achieved with tadalafil. Both methods of treatment had no negative effect on the size of the prostatic gland and PSA level except 2 patients with somatotropinoma on testosterone. In the course of chorionic gonadotropin treatment pituitary tumor increased in size in 3 patients.
Palavras-chave
Bibliografia
- Дедов И. И. (ред.). Диагностика и лечение нейроэндокринных заболеваний. М.; 2003.
- Йен С. С. К., Джаффе Р. Б. (ред.). Репродуктивная эндокринология. М.: Медицина; 1998; т. 1-2.
- Балаболкин М. И. Эндокринология. М. 1998. 582.
- Козлов Г. И. Реабилитация мужчин с нарушениями половых функций при различной эндокринной патологии: Дис. ... д-ра мед. наук. - М.; 1990.
- Sodi R., Fikri R., Diver M. et al. Testosterone replacement-induced hyperprolactinaemia: case report and review of the literature. Ann. Clin. Biochem. 2005; 42 (Pt 2): 153-159.
- Taniguchi H., Kawa G., Kinoshita H. et al. Male hypogonadotropic hypogonadism (MHH) outpatient with testosterone deficiency syndrome: a case report. Hinyokika Kiyo 2009; 55 (2): 107-109.
- Casunueva F. F., Molitch M. E., Schlechte J. A. et al. Guidelines of the Pituitary Society for the diagnosis and management of prolactimonas. Clin. Endocrinol. (Oxf.) 2006; 65 (2): 265-273.
- Cook D. M., Ezzat S., Katznelson L. et al. AACE medical guidelines for clinical practice for the diagnosis and treatment of acromegaly. Endocr. Pract. 2004; 10 (3): 213-225.
- Nieman L. K., Biller B. M. K., Findling J. W. et al. The diagnosis of Cushing's syndrome: An Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. 2008; 93 (5): 1526-1540.
- Реброва О. Ю. Статистический анализ медицинских данных. Применение пакета прикладных программ STATISTICA. М.; 2002.
- Young J. M., Feldman R. A., Auerbach S. M. et al. Tadalafil improved erectile functin at twenty-four and thirty-six hours after dosing in men with erectile dysfunction: US trial. J. Androl. 2005; 26: 310-318.
- Giuliano F., Varfnese L. Tadalafil: a novel treatment for erectile dysfunction. Eur. Heart J. Suppl. 2002; 4 (Suppl. H): 24-H31.
- Brock G., McMahon C., Chen K. et al. Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. J. Urol. (Baltimore) 2002; 168 (4, Pt 1): 1332-1336.
- Colao A., Paolo M., Diego F. Prostatic hyperplasia: An unknown feature of acromegaly. J. Clin. Endocrinol. 1998; 83 (7): 2606- 2607.
Arquivos suplementares
